A holistic approach to cell and gene therapies is crucial for the life science industry
Tracks
Track 3
| Friday, November 1, 2024 |
| 10:00 AM - 10:25 AM |
| Room 110 |
Overview
Sponsored: SYNEOS HEALTH
Details
Cell and gene therapies are revolutionising medicine, and they hold immense potential to transform health outcomes and the lives of Australia’s peoples. We are experiencing significant growth in this industry in part due to priority review pathways that fast-track therapeutics from bench to bedside and investment into genomic diagnostics. The therapeutic landscape remains strong globally with an increasing number of therapies approved for clinical use. Our keynote will outline why a holistic approach that considers clinical, operational and commercial capabilities, is needed to ensure promising technologies successfully progress through the pipeline.
Speaker
Mr Abhi Gupta
Senior Vice President & Head of Cell and Gene Therapy
Syneos Health
Keynote
